Exogenous estrogens and other factors in the epidemiology of breast cancer. 1981

J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White

In a hospital-based case-control study of the epidemiology of breast cancer undertaken in Connecticut from 1977 to 1979, there was no evidence of an increase in risk for breast cancer among women who had used oral contraceptives or estrogen-replacement therapy. In fact, there was some suggestion of a decrease in risk for breast cancer with increasing length of use of oral contraceptives. Higher than average risks were found among women who had never give birth to a child, women with a late age at menopause, women, with an early age at menarche, women who had given birth to their first child at a relatively late age, women with previous benign breast disease, and women with a history of breast cancer in a sister or mother. Heavy women were at high risk for premenopausal breast cancer. The association between heaviness and postmenopausal breast cancer was strongest among women who had had their last menstrual period more than 5 years before the diagnosis of breast cancer.

UI MeSH Term Description Entries
D008572 Menarche The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010298 Parity The number of offspring a female has borne. It is contrasted with GRAVIDITY, which refers to the number of pregnancies, regardless of outcome. Multiparity,Nulliparity,Primiparity,Parity Progression Ratio,Parity Progression Ratios,Ratio, Parity Progression,Ratios, Parity Progression
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D003237 Connecticut State bounded on the north by Massachusetts, on the east by Rhode Island, on the south by Long Island Sound, and on the west by New York.
D004812 Epidemiologic Methods Research techniques that focus on study designs and data gathering methods in human and animal populations. Epidemiologic Method,Epidemiological Methods,Methods, Epidemiologic,Epidemiological Method,Method, Epidemiologic,Method, Epidemiological,Methods, Epidemiological
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females

Related Publications

J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
November 1982, Journal of the National Cancer Institute,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
November 1981, American journal of epidemiology,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
March 1989, Cancer,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
January 1971, HSMHA health reports,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
April 1994, Ugeskrift for laeger,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
January 1983, Cancer detection and prevention,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
April 1976, Journal of the National Cancer Institute,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
January 1982, Breast cancer research and treatment,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
June 1976, Postgraduate medicine,
J L Kelsey, and D B Fischer, and T R Holford, and V A LiVoisi, and E D Mostow, and I S Goldenberg, and C White
January 1979, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!